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Abstract
Background: While the taxonomy and genomics of environmental strains from the P. fluorescens species-complex
has been reported, little is known about P. fluorescens strains from clinical samples. In this report, we provide the
first genomic analysis of P. fluorescens strains in which human vs. environmental isolates are compared.
Results: Seven P. fluorescens strains were isolated from respiratory samples from cystic fibrosis (CF) patients. The
clinical strains could grow at a higher temperature (>34 °C) than has been reported for environmental strains. Draft
genomes were generated for all of the clinical strains, and multi-locus sequence analysis placed them within
subclade III of the P. fluorescens species-complex. All strains encoded type- II, −III, −IV, and -VI secretion systems, as
well as the widespread colonization island (WCI). This is the first description of a WCI in P. fluorescens strains. All
strains also encoded a complete I2/PfiT locus and showed evidence of horizontal gene transfer. The clinical strains
were found to differ from the environmental strains in the number of genes involved in metal resistance, which
may be a possible adaptation to chronic antibiotic exposure in the CF lung.
Conclusions: This is the largest comparative genomics analysis of P. fluorescens subclade III strains to date and
includes the first clinical isolates. At a global level, the clinical P. fluorescens subclade III strains were largely
indistinguishable from environmental P. fluorescens subclade III strains, supporting the idea that identifying strains as
‘environmental’ vs ‘clinical’ is not a phenotypic trait. Rather, strains within P. fluorescens subclade III will colonize and
persist in any niche that provides the requirements necessary for growth.
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Background
Members of the P. fluorescens species-complex have ver-
satile metabolic capabilities, allowing them to thrive in a
large range of environments [1–4]. Strains of P. fluores-
cens produce a wide-range of secondary metabolites that
are important for their association with plants, such as
phenazine, polyketides, cyclic lipopeptides, biosurfac-
tants, phytohormones and metabolites that alter plant
hormone levels. However, many traits of P. fluorescens
also benefit its survival in a mammalian host, such as
the production of siderophores and bioactive metabolites
and the ability to form biofilms. While environmental
strains of P. fluorescens have optimal growth tempera-
tures between 4 °C and 28 °C, there are documented
cases of P. fluorescens strains with an expanded growth
temperature range that allow them to colonize humans
[5–8] or interact with human cells in vitro [9–11].
An increasing amount of evidence suggests that some
strains of P. fluorescens are members of the human
microbiota and interact with the human host in ways
that contribute to certain chronic diseases (reviewed in
[1]). For example, there is a strong link between the
presence of circulating antibodies to the P. fluorescens-
specific peptide I2 and such autoimmune diseases as
Crohn’s disease, celiac disease, chronic granulomatous
disease and ankylosing spondylitis. We have previously
reported that in the absence of acute disease, P. fluores-
cens is cultured from clinical respiratory specimens at a
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low rate in a hospital setting and is common in asymp-
tomatic lung transplant recipients [12]. P. fluorescens
strains are often isolated from respiratory specimens
from individuals with cystic fibrosis (CF), though this is
often unreported (unpublished observation). Additional
culture-independent analyses have identified P. fluores-
cens as a low-abundance member of the human
microbiome.
There is a large degree of genetic diversity among bac-
terial strains classified as P. fluorescens, which likely re-
flects the wide range of growth capabilities in these
bacteria. Using multi-locus sequence analysis (MLSA)
and 16S rRNA gene classification approaches, the P.
fluorescens-species complex can be divided into three
smaller taxonomic subclades [1–4, 13, 14]. Loper et al.,
used ten housekeeping genes (acsA, aroE, dnaE, guaA,
gyrB, mutL, ppsA, pyrC, recA, and rpoB) to divide seven
fully sequenced strains within the P. fluorescens-species
complex into these three distinct subclades [3]. Subclade
I includes P. chlororaphis 30–84, P. chlororaphis O6 and
P. protegens Pf-5; subclade II includes P. fluorescens Pf0-
1, P. fluorescens Q2-87 and P. brassicacearum Q8r1-96;
subclade III includes P. fluorescens A506, P. fluorescens
SBW25, and Pseudomonas sp. (now known to be P. syn-
xantha) BG33R. As expected, strains within a subclade
share a higher proportion of conserved domains than
the species-complex as a whole. While the core genome
of the P. fluorescens species-complex was found to be
comprised of 2,789 genes, the core genomes of subclades
I, II and III were found to be comprised of 4,188, 3,729
and 3,893 genes, respectively [3]. Comparative genomic
analysis revealed that these subclade divisions correlate
with potentially important functional differences. For ex-
ample, the genes necessary to produce a type-III secre-
tion system (T3SS) were found in subclades II and III,
but not subclade I [3].
Much work has been done on the taxonomy and
genomics of the P. fluorescens species-complex, but as
of yet, no strain isolated from a mammalian source
has been sequenced. Here we present the first com-
parative genomic analysis of P. fluorescens strains iso-
lated from humans. The seven P. fluorescens clinical
strains were isolated from respiratory specimens from
individuals with cystic fibrosis (CF), and represent the
first publically available draft genomes of human-
associated P. fluorescens strains. Phylogenetic analysis
reveals that these seven clinical strains fall within
subclade III of the P. fluorescens species-complex.
Our analysis reveals an extremely high degree of simi-
larity between the clinical and environmental isolates;
however, there are a number of genomic differences
between the clinical and environmental subclade III
strains, likely reflecting selective pressures unique in
the CF lung.
Results and discussion
Collection of P. fluorescens isolates
The clinical strains of P. fluorescens described in this
analysis were isolated over a seven-year period from re-
spiratory samples collected at five different hospitals
across the United States between March 2001 and
January 2008. Six were isolated from adults with CF (five
from sputum samples and one from a throat swab). One
was isolated from an infant with CF (Table 1). Initial
sequence-based analysis of the 16S rRNA-encoding gene
at the time of isolation was consistent with P. fluorescens
and indicated that they were not P. aeruginosa (data not
shown). Since each isolate came from different CF
patients from five different hospitals across a seven-year
period, each isolation likely represents a distinct bacter-
ial strain.
Phenotypic and growth properties
The phenotypic and growth properties of the newly se-
quenced clinical strains were compared to those of a
previously sequenced representative P. fluorescens strain,
SBW25. The clinical strains all displayed phenotypic
characteristics of bacteria within the P. fluorescens-spe-
cies complex, e.g., motile, gram-negative, coccobacillus,
lactose-fermentation negative, citrate growth positive,
and fluorescence under ultra violet (UV) light (data not
shown). While the clinical strains were phenotypically
similar to the environmental strains in the above listed
traits, they differed in their ability to grow at tempera-
tures above 30 °C. Environmental strains of P. fluores-
cens typically have an optimal growth range between 22
and 28 °C [1]. After 24 h, all of the clinical strains were
able to grow at 34 °C or higher in the laboratory, while
the environmental subclade III strain SBW25 was unable
to grow at this elevated temperature (data not shown).
Other investigators have reported that human isolates of
P. fluorescens have an increased temperature range for
growth [1, 5–8], consistent with our observations. The
Table 1 Date, location and source of P. fluorescens strains
Isolate ID Isolation Date Isolation Location Isolation Source
AU2989 4/4/01 Hartford, CT CF Throat Swab, Adult
AU6026 7/28/03 Seattle, WA CF Sputum, Adult
AU10973 4/6/06 Salt Lake City, UT CF Sputum, Adult
AU11518 7/12/06 Hartford, CT CF Sputum, Infant
AU14440 10/19/07 Little Rock, AR CF Sputum, Adult
AU14705 11/13/07 Augusta, GA CF Sputum, Adult
AU14917 1/11/08 Little Rock, AR CF Sputum, Adult
Date, location and source of clinical P. fluorescens subclade III strains. The
newly sequenced strains were isolated over a seven year period, between
March 2001 and Janurary 2008. Isolation occurred at five different hospitals
across the United States. Each strain was isolated from a separate patient
with CF
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newly sequenced clinical strains are able to grow at tem-
peratures at or above 32 °C but otherwise show the same
phenotypic and growth characteristics of previously
studied strains of P. fluorescens.
Genomic assembly
The seven clinical P. fluorescens strains were sequenced
on the Illumina HiSeq platform. Genomic DNA was pre-
pared for each strain and the paired-end read sequences
were partially de novo assembled using DNAstar’s
SeqMan NGen software. Assembly statistics of each of
the newly sequenced strains are shown in Additional file
1: Table S1. Contigs were assembled into scaffolds. Aver-
age coverage across genome ranged from 44X
(AU10973) to 68X (AU14705). As a methodologic con-
trol (sequencing and assembly), we also sequenced and
de novo assembled SBW25, which was included in our
subsequent analyses.
Genomic features
A summary of the genomic features of the P. fluorescens
strains is shown in Table 2. Genome size of the clinical
strains ranged between 6.1 megabase pairs (Mbps) and
6.88 Mbps. This is similar to the range seen in environ-
mental strains (5.95 - 6.72 Mbps). The GC content per
genome was also similar between clinical and environ-
mental strains (59.5 - 60.8 % versus 59.6 - 60.5 %, re-
spectively). All of the 16S rRNA gene sequences in the
clinical strains were >97 % nucleotide identical to that
found in P. fluorescens strain A506, with some being
>99 % nucleotide identical (Additional file 2: Table S2).
Phylogenetic analysis
To classify the newly sequenced clinical strains, we uti-
lized a multi-locus sequence analysis (MLSA) approach,
modified from the scheme described by Loper et al. [3]
(Fig. 1). All publically available genomes from the P.
fluorescens species-complex, and some additional strains
within the Pseudomonas genus, were included in the
phylogenetic analysis. The diverse environmental sources
of the fully sequenced P. fluorescens isolates have been
summarized in a recent review [1]. In our analysis, the
previously sequenced strains of P. fluorescens formed
three distinct phylogenetic subclades within the tree,
consistent with the initial publication of the phylogenetic
analysis of these strains (Fig. 1) [3, 15].
All seven clinical strains were placed within subclade
III of the P. fluorescens species - complex (Fig. 1). Strain
AU6026, isolated from CF sputum in Seattle, WA
(Table 1), segregated closest to environmental strain
A506, which was taken from a leaf surface isolate in
California [3]. Clinical strain AU10973, isolated from a
patient in Salt Lake, UT in 2006, segregated closest with
strain SBW25, isolated from a sugar beet in England.
Two separate sub-branches within subclade III con-
tained only clinical strains. AU14440, AU14917 and
AU14705 branched together on one sub-branch while
AU2989 and AU11518 branched together on a second,
clinical-only sub-branch. Figure 1 presents the phylogen-
etic analysis of sequenced clinical strains of P. fluores-
cens alongside sequenced environmental strains.
Additional phylogenetic analysis of the clinical isolates
was performed using average nucleotide identity (ANI)
and unweighted pair group method with arithmetic
mean (UPGMA) clustering (Fig. 2 and Additional file 3:
Table S3). ANI uses the shared nucleotide identity be-
tween bacteria genomes to infer taxonomic relation-
ships, where 95 % is considered the cut-off for species
delineation [14, 16]. The percent ANI shared between
members of subclade III ranged from 86 to 98.9 %
(Additional file 3: Table S3). The ANI between P. aerugi-
nosa PAO1 (a Pseudomonas sp. not found in the P. fluor-
escens species complex) and every P. fluorescens
subclade III strain was below 79 %. Both of these
Table 2 Genomic features of the P. fluorescens strains in this study
Genome Size (Mbp) G+C Content (%) # of Contigs & Scaffolds # of Coding Sequences # of RNAs Plasmid
AU2989 6.2 60.4 49 5569 58 No
AU6026 6.11 60 34 5427 67 No
AU10973 6.13 60.8 23 5499 61 No
AU11518 6.31 60.3 61 5684 63 No
AU14440 6.88 59.5 109 6123 71 No
AU14705 6.1 59.9 97 5379 69 No
AU14917 6.82 60.1 36 5592 68 No
A506 [3] 5.96 60 2 5267 69 (tRNAs) Yes (57.0)
SBW25 [3] 6.72 60.5 2 5921 66 (tRNAs) No
BG33R [3] 6.29 59.6 4 5511 68 (tRNAs) No
SS101 [3] 6.17 60 2 5374 68 (tRNAs) No
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numbers corresponded to previously determined intra-
and inter-species shared ANI [4]. In summary, both
MLSA and ANI analysis clearly revealed that each of the
clinical strains belong within subclade III.
Secondary metabolites
Members of the P. fluorescens species-complex are well-
documented to produce numerous secondary
metabolites necessary for living on plants and in the soil
and rhizosphere [3]. The genetic sequence of every gene
known to be involved in the production of the secondary
metabolites listed in Table 3 was used to screen the
newly sequenced clinical P. fluorescens strains using the
standalone BLASTn function provided by NCBI [17]
(Additional file 4: Table S4). The panel of genes involved
in the production of secondary metabolites found in the
Fig. 1 Phylogenetic tree of the P. fluorescens strains in this study. Multi-locus sequence analysis of the following eight housekeeping genes was
used to infer the phylogenetic tree: dnaE (DNA polymerase III alpha subuit); ppsA (phosphoenolpyruvate synthase); recA (Recombinase A); rpoB
(RNA polymerase subunit beta); gyrB (DNA gyrase subunit B); guaA (GMP synthease); mutL (DNA mismatch repair protein); pyrC (pyrimidine
biosynthetic enzyme dihydroorotase) and acsA (acetyl-CoA synthetase). The concatenated sequences were aligned with MAFFT as described in
the materials and methods. Clinical strains are highlighted in red [80, 81]
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clinical strains agrees with what has been reported from
previously sequenced P. fluorescens subclade III strains,
in terms of presence, absence and variable presence [3].
None of the strains screened contained the genes neces-
sary to make any of the seven P. fluorescens-associated
antibiotics (Table 3). In contrast, every strain contained
the full gene cluster to produce the siderophore pyover-
dine [18, 19] (Table 3). In addition to the major sidero-
phore pyoverdine, P. fluorescens strains produce multiple
secondary siderophores. The genes necessary to produce
the secondary siderophore, pseudomonine, were found
in clinical strain AU14705 and environmental strains
A506 and BG33R. Another secondary siderophore,
hemophore, is involved in the chelation of heme from
eukaryotic hosts [20]. The gene cluster required for the
biosynthesis and efflux of this siderophore was found in
clinical strains AU14705 and AU14917 and environmen-
tal strains SS101 and BG33R1. The environmental
strains A506, SS101 and BG33R1 are all known to pro-
duce chitinase [3] (Table 3). Three clinical strains,
AU6026, AU14705 and AU14917, also contained the
gene cluster necessary to produce this enzyme. Every
member of subclade III contained all four genes of the
exoprotease AprA gene cluster. Our analysis revealed
that clinically derived subclade III strains contain the
secondary metabolite gene clusters known to be present
in environmentally-derived subclade III strains.
Pan, accessory, core genomes
To determine the pan, accessory, and core genomes of
the subclade III P. fluorescens strains, we calculated the
number of clusters of orthologous groups of proteins
(COGS) shared among the strains. On average, the
strains in our study contained 5592 COGs per genome,
with a range of 5332–6123. The pan genome, which in-
cludes all COGs, shared and unshared, among all the ge-
nomes, consisted of 11,795 individual COGs (Fig. 3).
The core genome, which refers to only those COGs that
are shared between all genomes, contained 3612 COGs
(Fig. 3). The accessory genome, which is all the COGs
not part of the core, contained 8183 individual COGs.
Comparison of the genomes of the clinical strains and
the environmental isolates revealed that they share the
same general assortment of COGs. Clinical strains were
found to have additional copies of COGs involved in
metal-resistance, in particular, those of the czc-gene fam-
ily (Fig. 4a). Proteins produced through the czc gene
cluster are important in regulating resistance to poten-
tially toxic metals, such as zinc, copper, cobalt and cad-
mium, in gram-negative bacteria [21–25]. Though
members of the czc gene family were also found in en-
vironmental strains, clinical strains had up to twice as
many members of this gene family per genome (Fig. 4a).
This suggested that either duplication or genetic transfer
of the metal-resistance gene cluster occurred recently in
the clinical strains. While the identity of the conserved
protein families was the same across the subclade III ge-
nomes, COGs involved in metal resistance were found
in significantly higher numbers in the clinical strains.
Metal resistance genes
Environmental strains contained on average 18 genes
belonging to the czc gene cluster (range 17–19), while
clinical strains contained on average 33 czc-related
genes (range 23–47). The czcCBA gene cluster en-
codes for a resistance nodulation cell division (RND)-
type efflux pump that actively shuttles the metal
cations out of the bacterial cell [26, 27]. The expressed
CzcA protein constitutes the inner part of the of the RND
efflux pump, and is a chemiosmotic cation/proton anti-
porter driven by a H+ gradient [26, 27]. Focusing on just
the gene that encodes for the CzcA protein, environmen-
tal strains contained three czcA homologues each, while
clinical strains contained between three and eight czcA
homologues (Fig. 4a). To determine whether the presence
of additional copies of the czcA gene was due to recent
gene acquisition, the GC content across each czcA
homologue was compared to the GC content across the
entire genome of each strain. In the environmental strains,
Fig. 2 Phenogram based on average nucleotide identity (ANI)
between subclade III strains. Phenogram created based on a
similarity matrix of the average nucleotide identity (ANI) between
subclade III strains. Clustering performed using the Unweighted Pair
Group Method with Arithmetic mean (UPGMA) analysis
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Table 3 Secondary metabolite genes and gene clusters in subclade III strains
Antibiotics Siderophores
DAPG HCN Phenazine Pyrrolnitrin Rhizoxins Pyoluteorin Mupirocin Pyoverdine Pseudomonine Enantio-pyochelin Achromobactin Hemophore
Human-
associated
Isolates
AU2989 X
AU6026 X
AU10973 X
AU11518 X
AU14705 X X* X
AU14917 X X
Environment-
associated
Isolates
SBW25 UM X
P.fluorescens SBW25 X
P.fluorescens A506 X X
P. fluorescens SS101 X X
P. synxantha BG33R1 X X* X
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Table 3 Secondary metabolite genes and gene clusters in subclade III strains (Continued)
Exoenzymes Plant-Bacterial Communication
Mupirocin Pyoverdine Pseudomonine Enantio-
pyochelin
X X
X X X
X
X X
X X
X X
X X
X X
X X X
X X X
X X X
The presence or absence of a gene or gene cluster within each sequenced genome. The nucleotide sequence for the gene(s) involved in the biosynthesis of each secondary metabolite was used to query each
genome with the BLASTn function provided by NCBI. The chosen query nucleotide sequence for each gene is detailed in Additional file 4: Table S4. A ‘Yes’ destination corresponds to a BLASTn hit with an e value
<1×1015 and query and sequence identity >70%. The asterisk (*) indicates that one gene within the gene cluster fell below the cutoff
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Fig. 3 The pan, accessory and core genomes in subclade III strains. Each of the 11795 COGS was analyzed to determine how many genomes
encoded that particular COG (1–11, x-axis). Then the number of COGS encoded by only one genome, two genomes, etc. was determined (y-axis).
The pan genome contains the accessory and core. The average number of COGs per genome is 5592 (range: 5332–6123). The pan genome and
its compartments was calculated using the COGtriganle clustering algorithm in GET_HOMOLOGUES [82, 83]
Fig. 4 The czc gene cluster in environmental and clinical subclade III strains. A. The total number of genes annotated as belonging to the czcA gene
cluster in environmental and clinical subclade III strains. B. The percent G + C content of the czcA gene homologues. Open circles correspond to the G
+ C content found across the entire genome. Open circles correspond to the G + C content found across the entire genome. Arrows indicate the czcA
homologs enclosed in boxes in Fig. 5
Scales et al. BMC Genomics  (2015) 16:1032 Page 8 of 17
the czcA homologues had had similar GC content as that
found across the entire genome (Fig. 4b). In contrast, in
the clinical strains, there were czcA homologues that had
significantly lower GC content than that found across the
entire genome. Three czcA homologues (from AU6026,
AU11518 and AU14440) had more than a 5.5 % difference
in GC content when compared to the entire genome,
while two czcA homologues (from AU2989 and AU14440)
had more than a 12 % difference in GC content (Figs. 4b
and 5). This level of difference in GC content suggests
that these czcA gene clusters could represent recent events
of horizontal gene transfer.
To further investigate whether the clinical strains
gained additional czcA homologues through horizontal
gene transfer, we built a phylogenetic tree containing
the predicted amino acid sequences of the expressed
CzcA proteins from clinical and environmental sub-
clade III strains, as well as the amino acid sequences
of representative Pseudomonas and non-Pseudomonas
strains (Fig. 5). Each clinical strain had three CzcA
homologues that grouped with the three CzcA homo-
logues in the environmental strains (Fig. 5). Addition-
ally, the clinical strains contained a CzcA protein
whose most similar neighbor was the CzcA protein
from P. putida. The proteins expressed from czcA
gene homologues with significantly lower GC content
are labeled on the tree. The three CzcA proteins
expressed from genes with a GC content difference of
more than 5.5 % all grouped together in the tree, and
are most closely related to the CzcA proteins from P.
putida strains F1, KT2440 and GB-1, as well a CzcA
protein from P. fluorescens A11518 and AU14440.
The CzcA proteins expressed from czcA genes with
more than 12 % difference in GC content did not
branch off with any CzcA homologue from a Pseudo-
monas strain, but instead, branched with a protein
from Bradyrhizobium japonicum USDA110 (Fig. 5),
further suggesting that these gene copies were ac-
quired through recent horizontal gene transfer. Clin-
ical subclade III strains contain homologues of czcA
that show evidence of recent horizontal transfer from
non-Pseudomonas bacteria strains.
Fig. 5 Neighborhood-joining phylogenetic tree based on the
amino acid sequence of czcA homologues. czcA homologues
from clinical strains are highlighted in red; homologs from
environmental strains are highlighted in green; homologues from
other Pseudomonas spp. are highlighted in blue. Amino acid
sequences of the proteins expressed from czcA homologues
discovered in RAST [78]. All other bacteria species are publically
available on RAST. The amino acid sequences were aligned with
MAFFT [80, 81]
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GC islands
We performed total and segmented GC content scans
across the genomes of the newly sequenced clinical sub-
clade III strains to look for genomic regions of recent
horizontal gene transfer. The range in total GC content
of the newly sequenced clinical strains (59.5 to 60.8 %)
was similar to the range seen in the previously se-
quenced environmental strains (59.6 to 60.5 %) (Table 2).
However, the segmented GC scans revealed genomic re-
gions where the GC content dropped drastically from
the overall average (Additional file 5: Figure S1). We re-
ferred to the regions of lower GC content as Lower GC
Islands (LGCI) and those with more than a 15 % differ-
ence from the overall genome GC average were selected
for further investigation. We used the coordinates of the
LGCIs provided by the GC-Profile tool to select the nu-
cleotide sequence of the LGCI from each isolate’s gen-
ome. This nucleotide region was then used to screen the
non-redundant nucleotide database on NCBI with the
online megablast function (http://blast.ncbi.nlm.nih.gov/
Blast.cgi). The results of the LGCI nucleotide screens
are presented in Additional file 6: Table S5. The nucleo-
tide screens revealed that some of the LGCIs are more
genetically similar to Pseudomonas species outside of
the P. fluorescens species-complex, suggesting regions of
recent horizontal gene transfer into the clinical strains.
The PfiT/I2 region
Although PfiT/I2 has been identified as a P. fluorescens-
specific immunostimulatory protein, no one has yet
characterized the PfiT/I2 sequence in the genomes of
fully sequenced P. fluorescens strains. The PfiT/I2 region
of P. fluorescens encodes for an antigenic peptide (I2),
which has superantigen properties and is highly associ-
ated with various enteric and autoimmune diseases [28].
To investigate differences at the amino acid level, we
screened each subclade III strain using a local BLASTp
search with the published PfiT amino acid sequence [29]
and the top hit was selected from each genome to create
a multiple protein sequence alignment (Fig. 6). The ori-
ginal published P. fluorescens PfiT protein sequence was
used as a reference and the residues that differ from the
reference were highlighted in the figure. Just 29 of the
208 amino acids (13.9 %) showed any variation between
the strains. Seven of these amino acid changes were seen
in just one of the subclade III strains. Most notably, two
residues were altered in every strain: a threonine to an
isoleucine at position 80 and a lysine to a glutamic acid
at position 108. The PfiT protein was previously deter-
mined to belong to the TetR-family transcriptional regu-
lators and none of the substitutions that occurred in the
PfiT sequence from subclade III strains occurred in resi-
dues known to be important for DNA binding [28].
Thus, PfiT/I2 is highly conserved at the amino acid level
in all the P. fluorescens strains analyzed in our study.
Secretion systems
Type II secretion system
The Type II secretion system (T2SS), also known as the
general secretion (gsp) pathway, is a highly conserved
secretion system within Gram-negative bacteria and is
prevalent among gamma-proteobacteria [30, 31] and the
Fig. 6 Alignment of the PfiT amino acid sequences from subclade III strains. Amino acid sequence of the PifT protein aligned using MUSCLE [87].
Published sequence of PfiT used as reference (labeled PfiT) [27]. Only amino acids differing from reference are shown and colored. Percent
nucleotide consensus match visualized in green underneath alignment. Alignment visualized with DNAstar MegAligPro
Scales et al. BMC Genomics  (2015) 16:1032 Page 10 of 17
Pseudomonas genus [32]. The T2SS contains twelve core
components: an outer membrane secretin (GspD); a
cytoplasmic ATPase (GspE); an inner membrane protein
(GspF); major (GspG) and minor (GspH, I, J, K) pseudo-
pilins, proteins that assist with ATPase attachment to
the inner membrane and form an inner membrane plat-
form (GspL, M); a pre-pseudopilin peptidase/methyl-
transferase (GspO) and a protein possibly involved in
substrate recognition or secretion interactions (GspC)
[30, 33]. Gamma-proteobacteria can contain either one
[30], or multiple [34–36], set(s) of T2SS genes
(gspCDEFGHIJKLMO). Every subclade III strain but
AU14440 contained between one and three T2SS gene
clusters (Fig. 7 and Additional file 7: Table S6). These re-
sults agreed with what has been previously reported for
T2SS gene clusters in subclade III strains [3]. Clinical
strain AU14440 was missing five general secretion genes
(gspJKLMN). These missing genes are necessary for the
standard pilus structure of the T2SS [30, 33] and, there-
fore, AU14440 likely does not contain the standard type-
II secretion system found in other P. fluorescens strains.
Type III secretion system
Type-III secretion systems (T3SS) are needle-like struc-
tures that bacteria use to deliver effector proteins dir-
ectly into nearby host cells [37]. T3SSs fall into multiple
families based on the genetic structure and the macro-
molecular structure of the needle complex. The Hrp1
T3SS [38] is the most common T3SS found in the P.
fluorescens species-complex [3, 39–42]. The environ-
mental subclade III strains SBW25, BG33R, A506,
SS101, and the subclade II strains Q8r1-96 and Q2-87,
all contained at least one copy of a Hrp1 family T3SS
[3]. However, this system was not found in all P. fluores-
cens strains, as both Pf0-1 and Pf-5 did not have an
Hrp1 T3SS gene cluster [3, 43]. A list of the genes anno-
tated as belonging to the Hrp1 T3SS in the subclade III
P. fluorescens strains is reported in Fig. 7, with the full
annotated gene name shown in Additional file 7: Table
S6. The genes hrpD, hrpG, hrpQ and hrpT all vary in
whether or not they are included in the Hrp1 T3SS gene
cluster. Environmental strain SBW25 has been reported
to contain a functional T3SS [44], even though our ana-
lysis shows that it lacks hrpD and hrpQ, suggesting these
two genes are not required for T3SS function. Whether
or not HrpG and HrpT are required cannot be con-
cluded until the functionality of a T3SS in additional
subclade III strains is tested. Genes related to the Hrp1
T3SS were found in each of the subclade III strains ana-
lyzed. In summary, this is the first report demonstrating
that the genomes of clinically-isolated strains of P. fluor-
escens encode for a T3SS.
Type-IV secretion system
In P. aeruginosa, the T4SS genes pilABCDEFGHIJKLM-
NOPQRSTUVWXY1Y2Z are required for twitching mo-
tility [45] and the subclade III strains analyzed here were
missing between one and seven of the T4SS genes re-
quired for twitching motility in P. aeruginosa (Fig. 7 and
Additional file 7: Table S6). The Type-IV secretion sys-
tem (T4SS), also known as the Type-IV pili or fimbria, is
a three-dimensional filament on the surface of bacteria
that is important in adhesion, protease secretion and
motility [46]. As was seen in the T2SS gene cluster (Fig. 7
and Additional file 7: Table S6), AU14440 was missing
the largest number of T4SS-associated genes, lacking
homologues to pilBDGHLRT and the genes that encode
for the adhesins, FimA and FimD. Due to the large num-
ber of T4SS gene homologues missing in AU14440, it is
likely that this isolate does not contain a functional
Fig. 7 Genes that encode the Type-II, III, IV, VI and WCI secretion system in subclade III strains. Genes annotated using the RAST pipeline [77]. Full
gene names listed in Additional file 7: Table S6
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T4SS. The number of gene homologues for the T4SS
proteins adhesin, FimA and FimD, varied considerably
between the subclade III strains. FimA, a type IV fimbria
major subunit protein, shows the largest variation in
gene homologues per genome, ranging from none
(AU2989, AU11518 and AU14440) to four per genome
(AU10973). Thus, every clinical subclade III strain con-
tained a majority of the genes known to be required for
twitching motility in P. aeruginosa, with the strain
AU14440 missing the highest number of T4SS related
genes.
We further analyzed the fimA genes from a sample
group of subclade III strains (Additional file 8: Figure
S2). We aligned the genetic sequences of fimA from
A506, AU6026 and AU10973 using the MAFFT algo-
rithm (Additional file 8: Figure S2). The alignment re-
vealed that the genes annotated as fimA fall into two
major groups: fimA ‘a’ group and fimA ‘b’ group. Sub-
clade III strains A506 and AU10973 contained fimA ho-
mologues in both these two genetic groups. In addition,
A506 and AU10973 both contained fimA homologues
that fell within the same group but varied by single point
mutations. This analysis revealed that P. fluorescens sub-
clade III strains contained multiple homologues of the
fimA gene and homologues can vary by point mutations
along the sequence. As the fimA gene has only been an-
notated in a select number of Pseudomonas spp. (http://
www.pseudomonas.com/) it is not possible to know if
this level of redundancy is seen across the P. fluorescens
species-complex or the rest of the Pseudomonas genus.
Further analysis is required to understand the function
of multiple fimA genes in the subclade III strains.
Widespread Colonizing Island (WCI) / tad locus
The WCI has not previously been studied in P. fluorescens.
Due to its importance in colonizing new environmental
niches, the locus containing the tad genes is referred to as
the ‘widespread colonization island’ (WCI) [47]. The tad
locus is a newly described subtype of type II secretion sys-
tem [48]. Proteins expressed by the tad locus are import-
ant for biofilm formation and colonization of hosts in
multiple bacterial species. In P. aeruginosa, the genes
within the WCI are regulated by the same quorum sensing
circuit that regulates multiple virulence factors [49, 50].
All subclade III strains contained the ten WCI-associated
genes: cpaABCE and tadABCDG (Fig. 7). Based on the
presence and order of the genes in the tad locus, the P.
fluorescens subclade III strains analyzed in this study can
be predicted to encode a functional WCI.
Type VI secretion system
Here we surveyed the Type- IV secretion system (T6SS)
across the subclade III strains, and found that each
strain carried between 1–3 T6SS gene clusters (Fig. 7).
The T6SS is a macromolecular complex that either
transports bacterial effectors directly into target cells or
releases them into the extracellular medium [51]. Many
of the T6SS genes found in the P. fluorescens strains are
highly conserved across all bacterial strains that contain
a T6SS [52] (Fig. 7 and Additional file 7: Table S6). Every
P. fluorescens strain within this analysis contained at
least one copy of impABCDGHIJK, vasDH, ppA, ppKA,
dotU, icmF, clpB, clpV1, vgrG1 and vgrG2 genes. It has
been reported that at least 11 structural proteins and
two effector proteins (mainly Hcp and VgrG) are re-
quired to assemble a functional T6SS [52, 53]. Each sub-
clade III strain also contained multiple copies of the
effector proteins Hcp and VgrG. Multiple copies of ef-
fector proteins are thought to be tied to the multiple uti-
lizations of the T6SS within a bacterial cell, allowing a
bacterium to differently utilize the T6SS depending on
environmental conditions [53]. The newly- sequenced
human-associated subclade III strains contained multiple
copies of the structural T6SS genes, and a large number
of T6SS effectors, similar to what has been reported in
other P. fluorescens strains.
The number of vasH homologues annotated in the
subclade III strains ranged from two (AU10973 and
AU14705) to five (AU14440). VasH is a sigma-54
dependent transcriptional regulator that has been shown
to regulate transcription of the T6SS [54–56]. The sigma
factor 54 is an alternate sigma factor that functions as a
global regulator in multiple plant and animal associated
bacteria [57, 58]. Sigma factor 54 interacts with RNA-
polymerase and a sigma-54 dependent transcriptional
regulator (such as VasH) to initiate transcription at
sigma-54 dependent promoters [58, 59]. In order to in-
vestigate the differences between these vasH gene homo-
logues, we did a multiple sequence alignment of the
vasH genes from A506, AU6026, AU10973 and
AU14440 and assembled a phylogenetic tree (Additional
file 9: Figure S3). The separate vasH homologues fell
into four separate groups based on nucleotide sequence
similarity, labeled as groups ‘a’, ‘b’, ‘c’ and ‘d’. The vasH ‘a’
homologues showed the highest similarity to the vasH
from Vibrio cholera. AU14440 also contained an add-
itional copy of a vasH homologue that branches with the
Vibrio cholera vasH. AU10973 also has two copies of a
vasH homologue, one in branch ‘c’, and one in branch
‘d’. This analysis revealed that the different homologues
of vasH fell within distinct evolutionary groups based on
nucleotide similarity comparison.
Conclusions
We present the first comparative genomic analysis of
Pseudomonas fluorescens isolates from clinical samples.
Previously, all sequenced P. fluorescens strains had been
isolated from environmental samples, such as the soil,
Scales et al. BMC Genomics  (2015) 16:1032 Page 12 of 17
plant leaves and loam [1, 3]. Comparing the genome of
seven strains of P. fluorescens isolated from the lungs of
individuals with CF (Table 1) to four previously se-
quenced environmental strains within the same subclade
(III), we found that all eleven strains were very similar in
regard to global and individual genomic features
(Tables 2 and 3; Fig. 6). However, the clinical strains ana-
lyzed in this study differed from the environmental
strains in two important ways. Firstly, the strains isolated
from clinical samples had an increased temperature
growth range that allowed them to grow between 32 °C
and 37 °C, while the representative environmental strain
SBW25 could not grow above 28 °C. The finding that
the clinical isolates studied in this paper can grow at
32 °C or higher agrees with other accounts of strains of
P. fluorescens isolated from mammalian samples [5–8].
Changes in temperature often signal a change in envir-
onmental context, and bacteria have multiple mecha-
nisms to sense these changes, including signaling
through two-component sensor (TCS) systems [60]. It
remains to be determined whether differences in a spe-
cific TCS may account for this difference.
The clinical strains also differed significantly from envir-
onmental strains in the number of protein-coding genes
involved in the resistance nodulation cell division (RND)-
type of efflux pump that regulates zinc, cadmium and co-
balt ions in many gram-negative bacteria [24, 26, 61]. Ef-
flux pumps control the concentration of metal ions that
pass through a bacterial cell and there is strong evidence
for a link between resistance to metal ions and antibiotics
[61, 62]. Metals, such as zinc, are necessary for bacterial
growth in trace amounts. However, when in abundance,
metal cations become toxic to the bacterial cell. Zinc will
bind to free thiol groups, which can disrupt protein func-
tion [63]. The RND-type efflux pump produced by the
CzcCBA proteins is regulated by the CzcR-S two-
component system [26]. In P. aeruginosa, treatment with
zinc leads to the expression of the czcRS operon, which
then leads to transcriptional activation of czcCBA [61].
There is a link between the metal resistance conferred
through the czcCBA efflux pump and resistance to antibi-
otics, such as imipenem. The same two-component regu-
lator that turns on transcription of czcCBA also negatively
regulates the gene oprD. This gene encodes for the specific
porin, OprD, which is the primary route by which carba-
penems, such as impienem, enter into a bacterial cell [62].
In laboratory conditions, exposure to zinc can lead to
spontaneous mutations in the czcS sensor gene in P. aeru-
ginosa, making the bacteria resistant to imipenem expos-
ure [61]. Increased resistance to antibiotics has been seen
in multiple different metal-contaminated environments,
such as freshwater streams [64], costal areas [65], and
metal-contaminated ash settling basins [66]. GC content
and phylogenetic analysis of the czcA gene involved in
zinc, cadium and cobalt resistance suggested that clinical
strains obtained additional copies through horizontal gene
transfer from bacteria outside of the Pseudomonas genus.
Our findings that the clinical strains were highly similar
to environmental strains within the same phylogenetic
subclade is in itself significant because it highlights that
many of the qualities that P. fluorescens bacteria utilize to
succeed in the environment also benefit survival in a hu-
man host. Environmental and clinical strains of P. aerugi-
nosa are often very similar genomically [67, 68], with a
few notable differences that include increased temperature
growth range [69] and the acquisition of additional anti-
biotic resistance traits [70–74]. The clinical strains ana-
lyzed in our current study all fell into subclade III of the
P. fluorescens species complex; further studies will likely
that reveal clinical strains of P. fluorescens in each of the
phylogenetic divisions. The very definition of an “environ-
mental”, “clinical” or “human” strain is in fact an artificial
construct; bacteria will colonize and persist in any niche
that provides the requirements necessary for growth. As
more clinical strains of P. fluorescens are discovered, se-
quenced and analyzed, our understanding of what genetic
attributes are important for the various lifestyles of P.
fluorescens in its different niches is likely to expand and
become more refined.
Methods
Strain isolation, storage and 16S typing
The seven P. fluorescens strains were isolated between
March 2001 and January 2008, from five hospitals across
the United States (Hartord, CT; Seattle, WA; Salt Lake
City, UT; Little Rock, AR; Augusta, GA, Table 1). The ma-
jority (six strains) were isolated from sputum; one strain
was isolated from a throat swab. One strain was isolated
from an infant with CF. P. fluorescens SBW25 was kindly
provided by Dr. Stuart Levy (Tufts University). Isolates
were banked and stored at -80C. The universal primer set
8 F and 1492R [75] was used to amplify a portion of the
16S rRNA gene through PCR, which was then Sanger-
sequenced using an ABI 3730XL sequencer. Partial 16S
sequences were screened through NCBI’s nonredundant
nucleotide database and identified as P. fluorescens. Indi-
vidual strains were either streaked out on LB agar for
phenotypic assays or grown up aerobically overnight in
Luria Broth at 34 °C for DNA isolation.
Phenotypic assays
To determine the temperature range for growth, a single
colony was selected from an agar plate and grown in Luria
Broth aerobically for 18 h at room temperature (22 °C),
34 °C and 37 °C. The optical density at 600 nm was mea-
sured and compared to non-inoculated broth. Plates were
incubated at 34 °C for twenty-four hours and colony form-
ing were counted and used to calculate doubling time.
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All phenotypic assays were performed from a single
colony grown up from an −80 °C glycerol stock main-
tained in the lab. Fluorescence was assayed using an UV
light. Standard Gram-stain was used to determine
whether each strain was gram-negative or positive. Mo-
tility was assayed by looking for movement on a wet
mount under 100x magnification.
DNA isolation
Genomic DNA was extracted from 2 mL of overnight
culture growth using the DNeasy Blood and Tissue
Kit (Qiagen Cat# 69506) following manufacturer’s
recommendations.
Genome sequencing, assembly and annotation
Whole genome sequencing was performed at the
University of Michigan Sequencing Core on the Illumina
HiSeq 2000 platform with a 100-bp paired-end library.
Illumina reads were assembled de novo with the DNAs-
tar SeqMan NGen Version 12 software. The seven ge-
nomes were assembled into contigs and contigs were
ordered with the Mauve aligner ‘reordering contigs’
function [76] using a previously sequenced P. fluorescens
subclade III genome (A506) as a reference. Annotation
was performed using the automated online software
RAST [77, 78]. The presence or absence of secondary
metabolite genes was assayed through the BLASTn
function provided by NCBI [17] using a chosen query
sequence listed in Additional file 4: Table S4 and a cutoff
of evalue <1e15 and sequence identity >70 % [79].
Nucleotide sequence accession numbers
The draft genomes have been deposited at DDBJ/EMBL/
GenBank with accession numbers JRXT00000000,
JRXU00000000, JRXV00000000, JRXW00000000,
JRXX00000000, JRYA00000000, JRXY00000000, for iso-
lates AU2989, AU6026, AU10973, AU11518, AU14440,
AU14705, AU14917, respectively.
MLSA and phylogenetic analysis
Multi-locus sequence analysis was performed using the
concatenated sequences of the following housekeeping
genes- dnaE, ppsA, recA, rpoB, guaA, mutL, pyrC and
acsA- modified from the approach in Loper et al. [3].
The nucleotide sequences of the czcA homologues were
discovered in RAST and used to infer a phylogenetic
tree. The sequences used to construct the MLSA and
czcA homologue phylogenetic trees were aligned using
MAFFT [80, 81] and the trees were inferred using a
neighborhood-joining method with 1000 bootstraps.
Shared average nucleotide identity (ANI) was deter-
mined using the online software at http://enve-omics.-
ce.gatech.edu/ani [14]. A similarity matrix of the ANI
between the subclade III strains was created and
clustering performed using the Unweighted Pair Group
Method with Arithmetic mean (UPGMA) algorithm.
Pan, accessory and core genome and GC analysis
The pan, accessory and core genomes were calculated
using the COGtriangle algorithm [82] in GET_HOMO-
LOGUES [83]. The COG algorithm detects candidate
sets of orthologous proteins, with the given requirement
that included proteins are also found in at least three
evolutionarily distant species [84, 85]. Each protein rep-
resented by a COG is therefore thought to have evolved
from a single ancestral gene [84]. GC island content and
islands were calculated using the online GC profile tool
at http://tubic.tju.edu.cn/GC-Profile/ [86]. The GC-
Profile tool segments an inputted genome based on
parameters provided by the user and provides the GC
content across the genome segments, as well as the cu-
mulative GC content of the entire genome.
Analysis of individual genes
The amino acid sequence of PfiT from subclade III
strains was aligned using MUSCLE [87]. Alignment of
the fimA nucleotide acid homologues was performed
using the MAFFT algorithm [80, 81]. The nucleotide se-
quences of vasH homologues were aligned in Mauve
[88]. The PfiT, fimA and vasH alignments were visual-
ized using DNAstar’s MegaAlignPro software.
Availability of supporting data
The data sets supporting the results of this article are
available in the NCBI whole genome repository at
http://www.ncbi.nlm.nih.gov/genome/.
Ethics statement
The bacterial samples in this study were exempt from
ethics approval: they were provided by clinical micro-
biology labs, as de-identified cultures, with all patient
identifiers removed.
Additional files
Additional file 1: Table S1. Assembly statistics of the P. fluorescens
strains in this study. The paired end reads from Illumina HiSeq were de
novo assembled using the DNAstar SeqMan NGen. (PDF 387 kb)
Additional file 2: Table S2. The nucleotide sequence of the 16S rRNA
sequences was used to query the NCBI nucleotide collection (nr/nt). (PDF
170 kb)
Additional file 3: Table S3. Average nucleotide identity (ANI). Shared
average nucleotide identity between each strain in subclade III was
determined using the online tool at http://enve-omics.ce.gatech.edu/ani
[14]. Values presented in % shared ANI and ≥95 % shadowed in gray.
(PDF 370 kb)
Additional file 4: Table S4. Secondary metabolite genes and reference
organism for BLAST. Each gene involved in the production of the
secondary metabolites analyzed in Table 3 is listed in the left column.
The source organism of each gene’s nucleotide sequence used for the
Scales et al. BMC Genomics  (2015) 16:1032 Page 14 of 17
blast search is in the middle column. The NCBI ID for each source
organism is the right column. (PDF 54 kb)
Additional file 5: Figure S1. GC content calculated using the online
GC profile tool [86]. GC content displayed on y-axis and position in draft
genome displayed on x-axis. Arrows indicate GC islands that have been
further analyzed via NCBI BLASTn, results in Additional file 6: Table S5.
(PDF 559 kb)
Additional file 6: Table S5. BLAST results of selected GC Islands. The
nucleotide sequences of selected GC Islands (indicated with arrows in
Additional file 5: Figure S1) were used to query the NCBI nucleotide
collection (nr/nt). The top six results are displayed. (PDF 48 kb)
Additional file 7: Table S6. Full annotation of genes involved in
secretion systems in subclade III strains. Abbreviations on left correspond
to those found in Fig. 7 of paper. Fully annotated gene names are in the
right column, as provided by the RAST annotation pipeline [78].
(PDF 47 kb)
Additional file 8: Figure S2. Alignment of fimA homologues from
select environmental and clinical subclade III strains. fimA homologues
defined in RAST [78]. Nucleotide sequence of fimA homologues aligned
with the MAFFT algorithm within DNAstar’s MegAlign Pro software. A506
is a representative environmental strain; AU6026 and AU10973 are
representative clinical strains. (PDF 1267 kb)
Additional file 9: Figure S3. Phylogenetic tree inferred from the
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